Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on September 28, 2026

Sep. 28, 2026

Agent Memory Challenge Cycle 2 Opens Globally, Inviting More Teams to Benchmark the Future of AI Memory

Indeterminate GlobeNewswire

Sep. 28, 2026

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

Indeterminate GlobeNewswire

Sep. 28, 2026

NOVARC NAMED TO THE GLOBE AND MAIL’S LIST OF CANADA’S TOP GROWING COMPANIES

Indeterminate GlobeNewswire

Sep. 28, 2026

Telos Corporation Awarded $13.7 Million Contract to Modernize Cyber Risk Management for U.S. Department of Health and Human Services

Indeterminate GlobeNewswire

Sep. 28, 2026

Lifecore Biomedical to be Acquired by Webster Equity Partners

Indeterminate GlobeNewswire

Sep. 28, 2026

GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit

Indeterminate GlobeNewswire

Sep. 28, 2026

MBody AI Presents AI Robot Workforce Platform at Lytham Fall 2026 Conference

Indeterminate GlobeNewswire

Sep. 28, 2026

Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

Indeterminate GlobeNewswire

Sep. 28, 2026

New Laudio and AONL Research Links Clinical Ladder Advancement to Higher Nurse Retention, Reveals Early-Career Participation Gap

Indeterminate GlobeNewswire

Sep. 28, 2026

Lofty Launches MCP Server to Give Brokerages an Open Foundation for Their AI Strategy

Indeterminate GlobeNewswire

Sep. 28, 2026

Foresight Plans to Acquire 50.01% in a 270MW Capacity European Data Center Development Company

Indeterminate GlobeNewswire

Sep. 28, 2026

Kaltura Wins Best Interactive Content Platform in the 2026 Digiday Technology Awards

Indeterminate GlobeNewswire

Sep. 28, 2026

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

Indeterminate GlobeNewswire

Sep. 28, 2026

ROC Secures $64.3 Million U.S. Department of Justice Contract for Digital Evidence Technology

Indeterminate GlobeNewswire

Sep. 28, 2026

NETSOL Technologies reports record fiscal 2026 revenue and full-year profitability, exceeding guidance

Indeterminate GlobeNewswire

Sep. 28, 2026

Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden

Indeterminate GlobeNewswire

Sep. 28, 2026

Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik

Indeterminate GlobeNewswire

Sep. 28, 2026

4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME

Indeterminate GlobeNewswire

Sep. 28, 2026

Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4

Indeterminate GlobeNewswire